Judge denies request to restart Shkreli jury selection
NEW YORK (AP) — Jury selection at the securities fraud trial of a former pharmaceutical CEO notorious for price-gouging has hit a rough patch. Lawyers for Martin Shkreli (SHKREHL’-ee) complained Tuesday that news coverage is tainting the New York jury pool. During questioning Monday, several potential jurors said they couldn’t ignore Shkreli’s reputation for raising […]
Read more »